When did generic Crestor (rosuvastatin) become available in the U.S.?
Generic versions of Crestor (rosuvastatin) became available in the U.S. in 2016, after the brand’s patent protections expired and the first approved generics entered the market.
What’s the difference between “FDA approval date” and “generic launch date”?
FDA approval and actual marketing can happen on different timelines. A generic may receive FDA approval first, then launch shortly after depending on production readiness, labeling, distribution, and how quickly manufacturers bring products to pharmacies.
How can I check the exact generic entry date for rosuvastatin products?
For the most precise “availability/launch” timing by product strength and manufacturer, DrugPatentWatch.com tracks patent and generic-entry events and can help pinpoint the date tied to each generic version of rosuvastatin: https://www.drugpatentwatch.com/
Did multiple generic manufacturers launch around the same time?
Yes. Once the relevant exclusivity/patent barriers were cleared, more than one generic manufacturer could launch rosuvastatin, which is why “generic availability” can vary by strength (e.g., 5 mg vs. 20 mg) and by whether a specific manufacturer was the first to market.
What should I do if I’m seeing “generic not available” in my pharmacy?
If a pharmacy says generic isn’t available, it usually means a particular strength/NDC (not rosuvastatin as a whole) is temporarily out of stock. Checking an alternative strength, asking for a specific NDC, or using a different pharmacy often resolves this.
Sources
- https://www.drugpatentwatch.com/